{
  "id": "matr_300_138_1771349332108",
  "itemType": "matrixMatch",
  "version": "2026",
  "cognitiveProcess": "Analyze Cues",
  "topic": "Maternity Nursing",
  "subtopic": "High-Risk Pregnancy: Preeclampsia",
  "difficulty": 4,
  "stem": "A 32-year-old client at 34 weeks gestation (G1P0) was admitted at 1600 for preeclampsia with severe features and is receiving an intravenous infusion of magnesium sulfate. The nurse is reviewing the most recent assessment findings. For each finding, click to specify if it is an expected finding, indicative of a worsening condition, or indicative of magnesium sulfate toxicity.",
  "options": [
    {
      "id": "opt_3",
      "label": "Indicative of magnesium sulfate toxicity"
    },
    {
      "id": "opt_1",
      "label": "Expected finding for preeclampsia with severe features"
    },
    {
      "id": "opt_2",
      "label": "Indicative of worsening condition"
    }
  ],
  "prompts": [
    {
      "id": "prmpt_1",
      "label": "2+ pitting pedal edema"
    },
    {
      "id": "prmpt_2",
      "label": "Epigastric pain reported as 7/10"
    },
    {
      "id": "prmpt_3",
      "label": "Absent deep tendon reflexes (DTRs)"
    },
    {
      "id": "prmpt_4",
      "label": "Blood pressure of 164/112 mmHg"
    },
    {
      "id": "prmpt_5",
      "label": "Platelet count of 85,000/mm³ (85 x 10⁹/L)"
    },
    {
      "id": "prmpt_6",
      "label": "Urine output of 20 mL over the last hour"
    }
  ],
  "correctAnswer": [
    {
      "promptId": "prmpt_1",
      "optionId": "opt_1"
    },
    {
      "promptId": "prmpt_2",
      "optionId": "opt_2"
    },
    {
      "promptId": "prmpt_3",
      "optionId": "opt_3"
    },
    {
      "promptId": "prmpt_4",
      "optionId": "opt_1"
    },
    {
      "promptId": "prmpt_5",
      "optionId": "opt_2"
    },
    {
      "promptId": "prmpt_6",
      "optionId": "opt_3"
    }
  ],
  "answerBreakdown": {
    "correct": [
      {
        "promptId": "prmpt_1",
        "optionId": "opt_1",
        "rationale": "2+ pitting pedal edema is an expected finding in preeclampsia with severe features due to generalized vasospasm, increased endothelial permeability, and decreased plasma colloid osmotic pressure, leading to fluid shifting into interstitial spaces. This fluid shift is caused by the inflammatory response and endothelial dysfunction characteristic of preeclampsia.",
        "clinicalPearl": "Monitor edema, but remember it's an expected finding. Focus on more critical signs like BP, reflexes, and lab values.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_2",
        "optionId": "opt_2",
        "rationale": "Epigastric pain (or right upper quadrant pain) is a clinical manifestation of hepatic swelling and inflammation, often associated with HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome. In preeclampsia, endothelial damage and vasospasm can lead to liver ischemia and distension of the Glisson's capsule, causing pain. This indicates a worsening condition due to potential liver rupture or failure.",
        "clinicalPearl": "Epigastric pain in preeclampsia is a red flag for HELLP syndrome. Report immediately!",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_3",
        "optionId": "opt_3",
        "rationale": "Magnesium sulfate is a central nervous system depressant used to prevent seizures in preeclampsia. Loss of deep tendon reflexes is a critical sign of hypermagnesemia, indicating magnesium sulfate toxicity. Magnesium blocks calcium channels, reducing neuromuscular excitability. Absent DTRs precede respiratory depression and cardiac arrest.",
        "clinicalPearl": "Absent DTRs are a critical sign of magnesium toxicity. Stop the infusion and prepare to administer calcium gluconate.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_4",
        "optionId": "opt_1",
        "rationale": "A blood pressure of 160/110 mmHg or higher on two occasions at least 4 hours apart is a diagnostic criterion for preeclampsia with severe features. This hypertension results from generalized vasospasm and increased peripheral resistance due to endothelial dysfunction and increased sensitivity to vasoconstrictors. While critically high, it is an expected finding for the client's admitting diagnosis.",
        "clinicalPearl": "While high, this BP is expected with severe preeclampsia. Monitor closely for further increases or other signs of worsening.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_5",
        "optionId": "opt_2",
        "rationale": "A platelet count below 100,000/mm³ is a diagnostic criterion for HELLP syndrome. In preeclampsia, endothelial damage activates the coagulation cascade, leading to platelet aggregation and consumption. This thrombocytopenia indicates a worsening of the client's condition and increases the risk for hemorrhage.",
        "clinicalPearl": "Thrombocytopenia in preeclampsia suggests HELLP syndrome. Monitor for bleeding and prepare for potential blood transfusions.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_6",
        "optionId": "opt_3",
        "rationale": "Magnesium is primarily excreted by the kidneys. Oliguria (urine output < 30 mL/hr) is an early sign of magnesium sulfate toxicity because hypermagnesemia impairs renal function and reduces glomerular filtration rate, leading to decreased urine production. This decreased excretion further elevates magnesium levels, creating a dangerous cycle.",
        "clinicalPearl": "Decreased urine output with magnesium sulfate is a sign of toxicity. Reduce the infusion rate and notify the provider.",
        "scoring": "+/-"
      }
    ],
    "incorrect": [
      {
        "promptId": "prmpt_1",
        "optionId": "opt_2",
        "rationale": "While edema is present, it is very common in preeclampsia and even normal pregnancy. It is not, by itself, a reliable indicator of the disease worsening to a more severe state like HELLP syndrome or eclampsia. Other signs, such as worsening hypertension, neurological symptoms, or abnormal lab values, are more indicative of disease progression.",
        "clinicalPearl": "Edema alone is not a reliable indicator of worsening preeclampsia.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_1",
        "optionId": "opt_3",
        "rationale": "Edema is related to the pathophysiology of preeclampsia (fluid shifts), not the pharmacologic action of magnesium sulfate. Magnesium sulfate primarily affects the central nervous system and neuromuscular function, not fluid balance directly.",
        "clinicalPearl": "Magnesium sulfate does not directly cause edema.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_2",
        "optionId": "opt_1",
        "rationale": "Epigastric pain is not an expected finding. It is an ominous sign that indicates severe liver involvement and progression of the disease, requiring immediate notification of the healthcare provider. The pain results from distension of the liver capsule due to swelling and potential hemorrhage.",
        "clinicalPearl": "Epigastric pain is a serious sign in preeclampsia and should never be considered an expected finding.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_2",
        "optionId": "opt_3",
        "rationale": "Epigastric pain is a symptom of liver distension from the disease process of preeclampsia/HELLP syndrome, not a side effect or toxic effect of magnesium sulfate. Magnesium sulfate primarily affects the central nervous system and neuromuscular function.",
        "clinicalPearl": "Magnesium sulfate does not cause epigastric pain.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_3",
        "optionId": "opt_1",
        "rationale": "Clients with preeclampsia typically exhibit hyperreflexia (+3 or +4 DTRs) due to central nervous system irritability caused by cerebral edema and vasospasm. Absent reflexes are a profound deviation from the expected and a sign of severe CNS depression from magnesium toxicity.",
        "clinicalPearl": "Preeclampsia typically causes hyperreflexia, not absent reflexes.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_3",
        "optionId": "opt_2",
        "rationale": "Absent reflexes are not a sign of the underlying disease worsening (which would cause hyperreflexia), but rather a sign of iatrogenic overdose from the magnesium sulfate treatment. The magnesium is depressing the central nervous system excessively.",
        "clinicalPearl": "Absent reflexes are a sign of magnesium toxicity, not worsening preeclampsia.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_4",
        "optionId": "opt_2",
        "rationale": "Although severely elevated, this blood pressure is consistent with the client's diagnosis of 'preeclampsia with severe features'. A worsening condition would be indicated by a significant increase from this baseline, the onset of other symptoms like seizures, or development of HELLP syndrome.",
        "clinicalPearl": "This BP is expected for severe preeclampsia, but monitor for further increases.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_4",
        "optionId": "opt_3",
        "rationale": "Magnesium sulfate is an antihypertensive and CNS depressant. Toxicity would more likely be associated with hypotension, bradycardia, and respiratory depression, not severe hypertension. Hypertension is a primary symptom of preeclampsia itself.",
        "clinicalPearl": "Magnesium toxicity is more likely to cause hypotension, not hypertension.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_5",
        "optionId": "opt_1",
        "rationale": "The normal platelet count is 150,000 to 450,000/mm³. A count of 85,000/mm³ is significantly low (thrombocytopenia) and is not an expected feature of all cases of preeclampsia, but rather a sign of progression to HELLP syndrome, a severe complication of preeclampsia.",
        "clinicalPearl": "A low platelet count is not an expected finding in all preeclampsia cases; it suggests HELLP syndrome.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_5",
        "optionId": "opt_3",
        "rationale": "Low platelets are a result of the disease process (endothelial damage and platelet consumption) and are not caused by magnesium sulfate toxicity. Magnesium sulfate primarily affects the central nervous system and neuromuscular function.",
        "clinicalPearl": "Magnesium sulfate does not cause thrombocytopenia.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_6",
        "optionId": "opt_1",
        "rationale": "Adequate urine output (at least 30 mL/hr) is an expected finding and indicates proper renal perfusion. Oliguria (< 30 mL/hr) is a sign of a significant problem, such as hypovolemia, decreased cardiac output, or renal dysfunction.",
        "clinicalPearl": "Adequate urine output is expected; oliguria is a problem.",
        "scoring": "+/-"
      },
      {
        "promptId": "prmpt_6",
        "optionId": "opt_2",
        "rationale": "While worsening preeclampsia can cause renal failure and oliguria, in a client actively receiving magnesium sulfate, it is a primary and more immediate indicator of drug toxicity due to decreased renal excretion of the magnesium. The magnesium accumulates, leading to further CNS and neuromuscular depression.",
        "clinicalPearl": "Oliguria in a patient on magnesium sulfate is a primary indicator of drug toxicity.",
        "scoring": "+/-"
      }
    ]
  },
  "sbar": {
    "situation": "32-year-old (G1P0) at 34 weeks gestation admitted at 1600 for preeclampsia with severe features, receiving IV magnesium sulfate.",
    "background": "Client has a history of preeclampsia. Magnesium sulfate is being administered to prevent seizures, a common complication of preeclampsia. The goal is to maintain therapeutic magnesium levels without causing toxicity.",
    "assessment": "Current assessment findings include: 2+ pitting pedal edema, epigastric pain (7/10), absent DTRs, BP 164/112 mmHg, platelet count 85,000/mm³, urine output 20 mL/hr. Absent DTRs and low urine output are concerning for magnesium toxicity. Epigastric pain and low platelets are concerning for HELLP syndrome.",
    "recommendation": "Hold the magnesium sulfate infusion immediately due to signs of magnesium toxicity. Prepare to administer calcium gluconate to reverse the effects of magnesium. Notify the provider immediately about the epigastric pain and low platelet count, as these suggest HELLP syndrome, requiring further evaluation and management. Monitor vital signs, reflexes, and urine output closely. Consider ordering liver function tests and a complete blood count.",
    "clinicalPearl": "Remember the classic signs of magnesium toxicity: decreased or absent DTRs, decreased respiratory rate, and decreased urine output.",
    "scoring": "+/-"
  },
  "sentinelStatus": "healed_v2026_v8"
}